Coronavirus / COVID

Over 200 scientists issued alert to medical community that COVID-19 is transmissible over longer distances via smaller aerosolized droplets.

Despite being within the age group at highest risk for severe SARS-CoV-2 infection, a recent survey suggests that the population is not inherently more willing to socially isolate.

A report released for AIDS 2020 warns the international AIDS response could be set back substantially by ongoing events.

How the inflammatory-based syndrome is affecting US children during the COVID-19 pandemic.

A discussion on how the pediatric inflammatory syndrome has begun to affect the US months into the pandemic.

Black Americans bear a disproportional burden and negative outcomes from the coronavirus.

A discussion with a Yale expert on what new CDC data shows.

Judith Feinberg, MD, FIDSA, describes ongoing investigation into the immune response from COVID-19.

The purchase by Health and Human Services ensures US hospitals can secure the COVID-19 medication for the next few months.

BNT162b1, a SARS-CoV-2 vaccine candidate, elicited promising early signs of immune activity in a placebo-controlled phase 1/2 study.

A brief overview of our top stories.

Jonathan Spero, MD, discusses workplace safety in the time of SARS-CoV-2.

Recent concerns have been raised about a spike protein mutation in SARS-CoV-2. Are these fears grounded?

With more COVID-19 cases being realized in the US, the White House Coronavirus Task Force testified before the Senate today.

New recommendations are intended to aid biomedical firms in achieving licensure of a safe and effective vaccine.

Judith Feinberg, MD, FIDSA, describes surprising outcomes in many COVID-19 cases among people living with HIV.

In a recent CDC Morbidity and Mortality Weekly Report, data showed greater intensive care unit admission and mechanical ventilation for this group of patients.

A brief overview of our recent coverage.

Opaganib is set to be evaluated against SARS-CoV-2 in a multi-center, randomized, parallel arm, double-blind, placebo-controlled study.

Researchers have found 6 inflammatory molecules in critically ill patients, which might be used as therapeutic targets in fighting COVID-19.

The status of emergency departments in the city during the pandemic's migration west.

Bradley Sherman, MD, shares insight as to what goes into a respiratory ventilator recovery unit.

Four human coronavirus infection rates were relatively consistent among all age groups older than 4 years, the study also found.

A brief summary of the latest news.

A look at how the state became a belated hotspot, and what may help reduce future infection growth.